Idamycin PFS

Idamycin PFS is a brand name of idarubicin, approved by the FDA in the following formulation(s):

IDAMYCIN PFS (idarubicin hydrochloride - injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: February 17, 1997
  
  Strength(s): 1MG/ML ^[RLD][AP]

Has a generic version of Idamycin PFS been approved?

Yes. The following products are equivalent to Idamycin PFS:

idarubicin hydrochloride injectable; injection

• 
  Manufacturer: APP PHARMS
  
  Approval date: August 4, 2009
  
  Strength(s): 1MG/ML ^[AP]


• 
  Manufacturer: BEDFORD LABS
  
  Approval date: December 14, 2006
  
  Strength(s): 1MG/ML ^[AP]


• 
  Manufacturer: BEDFORD LABS
  
  Approval date: May 15, 2007
  
  Strength(s): 1MG/ML ^[AP]


• 
  Manufacturer: SANDOZ
  
  Approval date: March 29, 2011
  
  Strength(s): 1MG/ML ^[AP]

IDARUBICIN HYDROCHLORIDE PFS (idarubicin hydrochloride injectable; injection)

• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: May 1, 2002
  
  Strength(s): 1MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Idamycin PFS. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Idamycin PFS.

See also...

• Idamycin PFS Consumer Information (Wolters Kluwer)
• Idamycin PFS Consumer Information (Cerner Multum)
• Idamycin PFS Advanced Consumer Information (Micromedex)
• Idamycin PFS AHFS DI Monographs (ASHP)
• Idarubicin Consumer Information (Wolters Kluwer)
• Idarubicin Consumer Information (Cerner Multum)
• Idarubicin Intravenous Advanced Consumer Information (Micromedex)
• Idarubicin Hydrochloride AHFS DI Monographs (ASHP)